Skip to main content

Curanex Pharmaceuticals Inc

CURX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002025942

No open-market purchases or sales by Curanex Pharmaceuticals Inc insiders were filed in the last 90 days; 11 institutions reported holding it in 13F filings for Q2 2026, worth $89.0K in total; no superinvestor holds it.

13F holders, Q3 2025

Institutional positions in Curanex Pharmaceuticals Inc as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
10
+10 vs. Q2 2025
Shares held
286.1K
+286.1K vs. Q2 2025
Total value
$206.3K
+$206.3K vs. Q2 2025
New holders
10
0 more added
Sold out
0
0 more reduced

Compare with Q2 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CURX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2025: 10 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 10 institutionsQ4 2025: 11 institutionsQ1 2026: 8 institutionsQ2 2026: 11 institutions
Value heldQ3 2025: $206.3K
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $206.3KQ4 2025: $140.5KQ1 2026: $167.6KQ2 2026: $89.0K
Institutions holding CURX and their total value by quarter
QuarterHoldersValue
Q2 202611$89.0K
Q1 20268$167.6K
Q4 202511$140.5K
Q3 202510$206.3K
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q3 2025

Shares, value and share of portfolio for each institution holding Curanex Pharmaceuticals Inc; share changes are against Q2 2025.

Institutions holding CURX in Q3 2025
InstitutionSharesValue% of portfolioChange in sharesAction
UBS Group AG64,516$46.5K0.00%+64,516New
Citadel Advisors LLC64,067$46.1K0.00%+64,067New
Jane Street Group, LLC35,277$25.4K0.00%+35,277New
Two Sigma Securities, LLC32,435$23.4K0.00%+32,435New
Jump Financial, LLC27,200$19.6K0.00%+27,200New
Millennium Management LLC19,154$13.8K0.00%+19,154New
Geode Capital Management, LLC18,670$13.4K0.00%+18,670New
Scientech Research LLC14,480$10.4K0.00%+14,480New
Advisor Group Holdings, Inc.5,700$4.45K0.00%+5,700New
Barclays PLC4,594$3.31K0.00%+4,594New